Genomic and Precision Medicine: Primary Care: Third Edition
Viral Hepatitis
Publication
, Chapter
Tu, T; Patel, K; Shackel, NA
March 23, 2017
Viral hepatitis is a highly prevalent cause of human morbidity and mortality. Consequences of chronic infection include liver failure and liver cancer. Genomic medicine has seen significant advances in the management and prognosis of viral hepatitis infection. Polymorphisms in interferon response genes predict treatment responses and disease outcome in hepatitis C. Further, a range of genetic markers predict the likelihood of cirrhosis and liver cancer as well as the determining the prognosis of established disease in individuals with hepatitis-B and/or hepatitis-C virus infection. The future will see highly personalized risk assessment and individualized treatment based on genomic medicine approaches in patients with viral hepatitis.
Duke Scholars
DOI
ISBN
9780128006856
Publication Date
March 23, 2017
Start / End Page
317 / 340
Citation
APA
Chicago
ICMJE
MLA
NLM
Tu, T., Patel, K., & Shackel, N. A. (2017). Viral Hepatitis. In Genomic and Precision Medicine: Primary Care: Third Edition (pp. 317–340). https://doi.org/10.1016/B978-0-12-800685-6.00017-5
Tu, T., K. Patel, and N. A. Shackel. “Viral Hepatitis.” In Genomic and Precision Medicine: Primary Care: Third Edition, 317–40, 2017. https://doi.org/10.1016/B978-0-12-800685-6.00017-5.
Tu T, Patel K, Shackel NA. Viral Hepatitis. In: Genomic and Precision Medicine: Primary Care: Third Edition. 2017. p. 317–40.
Tu, T., et al. “Viral Hepatitis.” Genomic and Precision Medicine: Primary Care: Third Edition, 2017, pp. 317–40. Scopus, doi:10.1016/B978-0-12-800685-6.00017-5.
Tu T, Patel K, Shackel NA. Viral Hepatitis. Genomic and Precision Medicine: Primary Care: Third Edition. 2017. p. 317–340.
DOI
ISBN
9780128006856
Publication Date
March 23, 2017
Start / End Page
317 / 340